Renaissance Technologies
IH

Renaissance Technologies’s iHuman IH Stock Holding History

Renaissance Technologies’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,125
Closed -$34K – 3892
2023
Q3 		$34K Sell
11,125
-3,735
-25% -$11.5K ﹤0.01% 3456
2023
Q2 		$44K Buy
14,860
+2,160
+17% +$6.69K ﹤0.01% 3639
2023
Q1 		$41K Buy
12,700
+200
+2% +$644 ﹤0.01% 3703
2022
Q4 		$33K Buy
+12,500
New +$25.4K ﹤0.01% 3872
2021
Q4 		– Sell
-19,516
Closed -$92K – 4050
2021
Q3 		$92K Buy
+19,516
New +$145K ﹤0.01% 3329

Other funds holding IH

APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Renaissance Technologies's IH Position: Q4 2023 in Review

Renaissance Technologies sold out of iHuman (IH) in Q4 2023, closing a stake of 11,125 shares — an estimated $34K sold.

Renaissance Technologies first reported a position in IH in Q3 2021 and held it in 5 quarters. The position peaked at $92K in Q3 2021. 4 funds tracked by Wall St. Rank hold IH as of Q4 2023.

  • Renaissance Technologies reported no remaining iHuman position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 11,125 iHuman shares in Q4 2023, an estimated $34K.
  • Renaissance Technologies first reported a position in iHuman in Q3 2021 and held it in 5 quarters.
  • Renaissance Technologies's iHuman position peaked at $92K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held iHuman as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.